Oxford Immunotec: Stefan Linn
Oxford Immunotec announced in a filing with the US Securities and Exchange Commission that its COO Stefan Linn has resigned to pursue other interests. Linn has been COO at the firm since August 2017. Prior to joining Oxford Immunotec, he was a senior vice president at IMS Health. Before that, he was a director at TPG Capital. He was also at McKesson where he was a senior vice president an president of Health Mart, McKesson's franchise pharmacy business.